Mark M. Goodman

Emory University — United States

Medicine · Health Sciences

53h-index9.5kcitations361works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(92), Neuroscience and Neuropharmacology Research(52), Radiopharmaceutical Chemistry and Applications(49), Neurotransmitter Receptor Influence on Behavior(45), Cancer, Hypoxia, and Metabolism(39)

Publications361 total

Rapid and Scalable Synthesis of Oxazoles Directly from Carboxylic Acids
The Journal of Organic Chemistry·2025· 1 citedOpen Access
Oxytocin and vasopressin 1a receptor alterations in the superior temporal sulcus and hypothalamus in schizophrenia
Social Neuroscience·2025
Synthesis, radiolabeling, and biological evaluation of methyl 6-deoxy-6-[<sup>18</sup>F]fluoro-4-thio-α-<scp>d</scp>-maltotrioside as a positron emission tomography bacterial imaging agent
RSC Advances·2025· 1 citedOpen Access
Synthetic Efforts toward the Synthesis of a Fluorinated Analog of 5-Aminolevulinic Acid: Practical Synthesis of Racemic and Enantiomerically Defined 3-Fluoro-5-aminolevulinic Acid
The Journal of Organic Chemistry·2024· 4 citedOpen Access
Oxytocin and vasopressin 1a receptor alterations in the superior temporal sulcus and hypothalamus in schizophrenia
2024Open Access
Alterations in adolescent brain serotonin (5HT)1A, 5HT2A, and dopamine (D)2 receptor systems in a nonhuman primate model of early life adversity
Neuropsychopharmacology·2024· 6 cited
Isothermal titration calorimetry analysis of the binding between the maltodextrin binding protein malE of Staphylococcus aureus with maltodextrins of various lengths
Biochemical and Biophysical Research Communications·2024· 3 citedOpen Access
Concise and Scalable Radiosynthesis of (+)-[<sup>18</sup>F]MDL100907 as a Serotonin 5-HT<sub>2A</sub> Receptor Antagonist for PET
ACS Chemical Neuroscience·2023· 2 citedOpen Access
PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration
Neuropsychopharmacology·2023· 14 citedOpen Access
Supplementary Figures 1 - 3 from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Methods from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Figure Legend from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Figures 4 - 8 from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Methods from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Data from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Data from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Figures 4 - 8 from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Figures 1 - 3 from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Supplementary Figure Legend from Arylsulfonamide KCN1 Inhibits &lt;i&gt;In Vivo&lt;/i&gt; Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP
2023Open Access
Data from CXC Chemokine Receptor-4 Antagonist Blocks Both Growth of Primary Tumor and Metastasis of Head and Neck Cancer in Xenograft Mouse Models
2023Open Access
page 1 of 19Next →

Frequent Co-authors

David M. Schuster(16), John R. Votaw(14), Jonathon A. Nye(10), Peter T. Nieh(8), Raghuveer Halkar(8), Weiping Yu(7), Viraj A. Master(7), Oluwaseun Odewole(6), Bital Savir-Baruch(6), Shuntaro Oka(5), Ronald J. Voll(5), Laurent Martarello(5), Jonathan McConathy(5), Zhongxing Liang(4), Hyunsuk Shim(4), F. DuBois Bowman(4), Leonard L. Howell(4), Ashesh B. Jani(4), Funmilayo Tade(4), Hiroyuki Okudaira(4)